Kabazitaksel Sandoz 10 mg/ml koncentrat za otopinu za infuziju
| Name | Kabazitaksel Sandoz 10 mg/ml koncentrat za otopinu za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-054988103 |
| Active Substance | kabazitaksel hidrat |
| Composition | 1 ml koncentrata za otopinu za infuziju sadrži 10 mg kabazitaksela (u obliku kabazitaksel hidrata) |
| Pharmaceutical Form | koncentrat za otopinu za infuziju |
| Manufacturer | Fareva Unterach GmbH, Unterach, Austrija Ebewe Pharma GmbH Nfg. KG, Unterach am Attersee, Austrija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 12.10.2020 |
| MA Period of Validity | 12.10.2025 |
| Classification Number | UP/I-530-09/19-01/67 |
| Registration Number | 381-12-01/70-20-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01CD04 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
